SLN-500

N/A

Report date: 2022/02/16 13:34:23

Base Information

Drug NameSLN-500
Drug Alias NameSLN-500
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionComplement C3 inhibitorsComplement system proteins inhibitorsRNA interference
TargetsComplement C3Complement system proteins
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSilence Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesSilence TherapeuticsMallinckrodt Plc
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A